Laser Vaginal Rejuvenation Risks

28 Mar 2019

Karen Stephens

by Karen Stephens

Female doctor with worried looking female patient

The US Food & Drug Administration (FDA) issued a warning in July 2018 about energy-based devices for vaginal ‘rejuvenation’ or vaginal cosmetic procedures. The FDA warned that the safety and effectiveness of these procedures has not been established. Potential serious adverse events include burns, scarring, pain during sexual intercourse and recurring/chronic pain.

The Urological Society of Australia and New Zealand supported the FDA statement in a media release in August 2018. They noted that these procedures also have potential to cause psychological damage and to prevent patients seeking appropriate evidence-based therapies. RANZCOG and ACOG have previously issued statements advising caution with these procedures.

The first published randomised controlled trial of laser treatment for vaginal atrophy was criticised for its design and conclusions in the Medical Journal of Australia in November 2018.

Doctors performing laser vaginal ‘rejuvenation’ with energy-based devices are advised to contact their MDO to ensure they are indemnified. MDA National is changing the level of cover required. It is important that any MDA National Member who is performing laser vaginal ‘rejuvenation’ contacts our Member Services team, even where cover has been previously approved.

Practitioners considering performing laser vaginal ‘rejuvenation’ are advised to:

  • Critically evaluate the literature
  • Critically evaluate the training in use of the device
  • Design a thorough consent process which informs patients of:
    • all potential adverse consequences
    • alternative treatments
    • lack of scientific evidence and lack of TGA approval for the device for the particular procedure
    • expected cost and that there is no Medicare rebate
    • variation in appearance of normal female genitalia
  • Inform the TGA of any adverse outcomes.

This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.



Doctors Let's Talk: Get Yourself A Fricking GP

Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.


25 Oct 2022

Systematic efforts to reduce harms due to prescribed opioids – webinar recording

Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme. 

Diplomacy in a hierarchy: tips for approaching a difficult conversation

Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.